ArticleAdvances in experimental medicine and biology2022
Graphene as Photothermal Therapeutic Agents.
Article in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nanoparticle-Enabled Photothermal Therapy Integrated with Gene Delivery, Immunotherapy, and Chemotherapy: A Comprehensive Review.International journal of nanomedicine · 2026Review
- Biological Safety Analysis of Nanoparticles: Exploring Toxicity, Mechanisms, and Safety Factors for Pharmaceuticals.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Light-assisted hyperthermic therapy is a promising strategy to treat cancer. Graphene and their derivatives with unique physiochemical properties, intrinsic near infrared absorption, and ability to transduce the absorbed light energy into heat, have attracted researchers to use them for photothermal therapy (PTT). In addition, the presence of surface functional groups and large surface area that can facilitate interactions with hydrophobic molecules has favored the use of graphene allotropes for developing PTT-based combinatorial therapies. In this book chapter we have reviewed different graphene-based PTT-assisted photodynamic, gene, chemo, and immunotherapeutic strategies developed to improve the outcome of cancer treatment. We have also discussed how PTT from graphene derivatives can improve the therapeutic outcomes of gene, chemo, and immunotherapies. Finally, this book chapter provides promising insights to develop novel graphene-based multifunctional PTT-assisted combinatorial therapeutics with both imaging and therapeutic regimens to treat cancer.
Indexed as
Identifiers
35175617What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.